SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fredun Pharmaceuticals establishes new manufacturing facility in Palghar

29 Apr 2026 Evaluate

Fredun Pharmaceuticals has established a new manufacturing facility in Palghar, Maharashtra, marking the addition of its fifth facility. This marks a significant step in the company’s expansion journey. The facility is expected to be operational by October 2026.

The company remains committed to maintaining high standards of quality, compliance, and innovation while strengthening its position as a leading manufacturing partner in the healthcare industry. 

Fredun Pharmaceuticals is engaged in manufacturing of pharmaceutical products.


Fredun Pharma Share Price

2406.00 31.05 (1.31%)
11-May-2026 13:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1874.60
Dr. Reddys Lab 1293.90
Cipla 1314.55
Zydus Lifesciences 947.25
Lupin 2270.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×